Table 1.

Patient characteristics for all subjects in GOG 214

Treatment
LevonorgestrelPlaceboTotal
CharacteristicN (%)N (%)N (%)
Age group
 30–394 (12.1)6 (19.4)10 (15.6)
 40–4914 (42.4)13 (41.9)27 (42.2)
 50–5914 (42.4)9 (29.0)23 (35.9)
 60–691 (3.0)3 (9.7)4 (6.3)
Ethnicity
 Hispanic or Latino2 (6.1)0 (0)2 (3.1)
 Non-Hispanic29 (87.9)27 (87.1)56 (87.5)
 Unknown/not specified2 (6.1)4 (12.9)6 (9.4)
Race
 Race unknown0 (0)1 (3.2)1 (1.6)
 American Indian/Alaskan Native2 (6.1)0 (0)2 (3.1)
 White31 (93.9)30 (96.8)61 (95.3)
Menopausal status
 Premenopausal20 (60.6)19 (61.3)39 (60.9)
 Postmenopausal13 (39.4)12 (38.7)25 (39.1)
Total33 (51.6)31 (48.4)64 (100.0)